Key facts
- This page summarizes Conor Kilroy's Form 4 filing for Aura Biosciences, Inc. (AURA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Jul 2026, 16:35.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in two substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.
SEC remarks
Chief Legal Officer and Secretary